A single-centre retrospective observational case series evaluating prognostic significance of macular capillary drop-out and previous panretinal laser photocoagulation in treatment-naive patients with diabetic macular oedema treated with intravitreal ranibizumab.
Latest Information Update: 14 Oct 2016
Price :
$35 *
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 14 Oct 2016 New trial record